06 Dec 2025
by Jim Rose
in health economics, politics - USA
Tags: health insurance
As Craig Garthwaite and Timothy Layton point out: “Originally a small, inexpensive safety-net program, Medicaid has grown into a major national health-insurance provider, covering nearly one in four Americans and more people than the public health insurance programs of the United Kingdom, Germany, or France.” They review the program and offer some recommendations in “Coverage Isn’t…
Medicaid: What It Has Become
06 Oct 2025
by Jim Rose
in health economics, politics - USA
Tags: health insurance
Paul Krugman has a recent post defending the exchange subsidies and tax credits that the Republicans wish to cut, talking with Jonathan Cohn about the “premium apocalypse” (and here). Whether or not one agrees with Krugman normatively, the arguments if anything convince me that Obamacare probably is not financially or politically stable. To recap some […]
The unraveling of Obamacare?
02 Apr 2025
by Jim Rose
in health economics, politics - New Zealand
Tags: health insurance
Last week doctors and Green MPs were criticising the use of private hospitals to cut surgical waiting lists. This week the numbers show that patients are winning from private care: Partnering with the private health sector is delivering better access and shorter wait times for elective treatment, Health Minister Simeon Brown. “Ensuring Kiwis have access […]
Patients win with private care
06 Mar 2024
by Jim Rose
in applied price theory, comparative institutional analysis, development economics, growth miracles, health economics, industrial organisation
Tags: health insurance, Singapore
Besides the usual, that is. Max Thilo of the UK has a new and excellent study on this, here is one excerpt from the foreword by Lord Warner: Second, and critical, the Singaporeans are not fixated on delivering services from acute hospitals – the most expensive part of any healthcare system because of its fixed […]
What can be learned from Singaporean health care institutions?
28 Feb 2024
by Jim Rose
in applied price theory, economics of information, entrepreneurship, health economics
Tags: adverse selection, health insurance, moral hazard, screening, self-selection, signaling
Genetic testing identifies disease risk, enabling individuals to dodge environmental triggers, optimize treatments, and improve planning. Yet, the fear of increased insurance premiums deters many from undergoing tests. Genetic testing offers societal benefits but also presents significant distributional challenges. To address this, my 1994 paper proposed the idea of genetic insurance. For a small fee […]
Genetic Insurance
Previous Older Entries
Recent Comments